What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Antibiotics
- Bacteria
Alan Forrest mainly focuses on Pharmacokinetics, Antibacterial agent, Pharmacodynamics, Pharmacology and Internal medicine.
His Pharmacokinetics research integrates issues from Oral administration, Chemotherapy, Urology, Renal function and Dose.
His study in Antibacterial agent is interdisciplinary in nature, drawing from both Minimum inhibitory concentration, Immunology and Linezolid.
His Pharmacodynamics research incorporates elements of Lesion, Area under curve, Combination therapy, Maturation inhibitor and Drug.
His Pharmacology research includes elements of Ciprofloxacin, Polymyxin B and Colistin.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Surgery.
His most cited work include:
- Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. (964 citations)
- Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia (769 citations)
- Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections (581 citations)
What are the main themes of his work throughout his whole career to date?
Pharmacokinetics, Pharmacology, Pharmacodynamics, Internal medicine and Microbiology are his primary areas of study.
The study incorporates disciplines such as Oral administration, Anesthesia, Antibacterial agent and Renal function in addition to Pharmacokinetics.
His Antibacterial agent research incorporates themes from Ciprofloxacin and Immunology.
Many of his research projects under Pharmacology are closely connected to Crossover study with Crossover study, tying the diverse disciplines of science together.
While the research belongs to areas of Pharmacodynamics, he spends his time largely on the problem of Polymyxin, intersecting his research to questions surrounding Acinetobacter baumannii.
The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology, Surgery and Oncology.
He most often published in these fields:
- Pharmacokinetics (59.57%)
- Pharmacology (42.28%)
- Pharmacodynamics (36.11%)
What were the highlights of his more recent work (between 2013-2021)?
- Pharmacokinetics (59.57%)
- Pharmacology (42.28%)
- Polymyxin (13.58%)
In recent papers he was focusing on the following fields of study:
Alan Forrest focuses on Pharmacokinetics, Pharmacology, Polymyxin, Pharmacodynamics and Polymyxin B.
His work deals with themes such as Anesthesia, Renal function, Nephrotoxicity and Liter, which intersect with Pharmacokinetics.
His studies deal with areas such as Antibiotics, Toxicity and Intensive care medicine as well as Pharmacology.
His Antibiotics study incorporates themes from Salvage therapy, Antimicrobial and Bacteria.
His biological study spans a wide range of topics, including Colistin, Pseudomonas aeruginosa, Acinetobacter baumannii and Drug resistance.
Alan Forrest works mostly in the field of Pharmacodynamics, limiting it down to topics relating to Tazobactam and, in certain cases, Ceftolozane.
Between 2013 and 2021, his most popular works were:
- International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). (176 citations)
- Dosing guidance for intravenous colistin in critically-ill patients. (125 citations)
- Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform? (103 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Antibiotics
- Bacteria
Alan Forrest mainly investigates Polymyxin, Polymyxin B, Microbiology, Colistin and Pharmacokinetics.
His work focuses on many connections between Polymyxin and other disciplines, such as Pharmacodynamics, that overlap with his field of interest in Combination therapy.
His Microbiology study incorporates themes from Bacterial outer membrane, Metabolome and Acinetobacter baumannii.
The Colistin study combines topics in areas such as Renal function, Renal replacement therapy, Critically ill, Intensive care medicine and Pharmacology.
Renal function is a subfield of Internal medicine that Alan Forrest explores.
His work deals with themes such as Anesthesia, Antibiotics, Liter and Dosing, which intersect with Pharmacokinetics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
